SEC Mandates Activist Investors Disclose Clients in Filings

The U.S. Securities and Exchange Commission (SEC) has updated its guidance to require activist investors to disclose the identities of their clients in key regulatory filings. The move represents a significant push for transparency that could disrupt the secretive nature of hedge fund campaigns.

SEC Clarifies Disclosure Rules

In an updated interpretation of its corporate finance rules issued Thursday, the SEC clarified its stance on disclosure requirements for 13D filings and proxy statements. According to legal experts cited by Reuters, the new guidance was not widely expected.

The regulator’s guidance specifies that activists must identify their underlying investors in certain situations. Key clarifications include:

• The identities of investors in a special purpose vehicle or "sidecar" formed to acquire a specific company's securities for an activist campaign must be disclosed (Question 110.09).
• Clients who have invested more than $500 are considered "participants" in a limited partnership that is soliciting votes to change a company's board (Question 155.02).

Impact on Activist Investing

Ad

This new interpretation directly challenges the secrecy that activist funds have long argued is crucial to their business models. Hedge funds often maintain that revealing their investors, or limited partners, could expose their strategies to competitors and limit their ability to execute campaigns effectively.

The guidance takes particular aim at the increasing use of special purpose vehicles, which allow clients to invest in a specific campaign rather than a fund's main portfolio. Conversely, companies targeted by activists have argued that greater transparency about who is funding a campaign is necessary information for them to mount a defense.

Context and Precedent

The SEC's move comes amid a busy first half of 2026 for shareholder activism, with firms like Elliott Investment Management and Ancora Alternatives launching campaigns at companies such as Warner Bros Discovery and Devon Energy.

The issue of investor disclosure previously came to a head in 2022 when medical device firm Masimo Corp. amended its bylaws to force activist Politan Capital to name its limited partners. The bylaw change sparked significant backlash from the investment community, and Masimo reversed the policy in early 2023.